Merck KGaA Company Profile (OTCMKTS:MKGAY)

About Merck KGaA

Merck KGaA logoMerck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company diversifies its activities into four business divisions: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of chemical and biotechnological origin. The Consumer Health division comprises the over-the-counter products for preventive health care and self-treatment of minor ailments. The Merck Serono and Consumer Health divisions form together the Company's Pharmaceutical business sector. The Merck Millipore division comprises the activities of the Millipore Corporation. The Performance Materials division consists mainly of the Liquid Crystals and Pigments & Cosmetics business units. The Company operates through numerous subsidiaries, including Peer+ BV, AZ Electronic Materials (AZ) and Ormet Circuits Inc., a material supplier for the semiconductor industry.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: MKGAY
  • CUSIP:
Key Metrics:
  • Previous Close: $35.33
  • 50 Day Moving Average: $35.94
  • 200 Day Moving Average: $31.86
  • Trailing P/E Ratio: 29.26
  • Foreward P/E Ratio: 5.23
  • P/E Growth: 2.25
  • Market Cap: $46.13B
  • Outstanding Shares: 1,305,639,000
Additional Links:
Companies Related to Merck KGaA:

Analyst Ratings

Consensus Ratings for Merck KGaA (OTCMKTS:MKGAY) (?)
Ratings Breakdown: 7 Hold Ratings, 6 Buy Ratings
Consensus Rating:Hold (Score: 2.46)
Consensus Price Target: $59.60

Analysts' Ratings History for Merck KGaA (OTCMKTS:MKGAY)
Show:
DateFirmActionRatingPrice TargetDetails
8/12/2016Berenberg BankDowngradeBuy -> HoldView Rating Details
5/25/2016DZ Bank AGReiterated RatingBuyView Rating Details
5/19/2016JPMorgan Chase & Co.Reiterated RatingNeutralView Rating Details
5/17/2016Citigroup Inc.Reiterated RatingBuyView Rating Details
5/9/2016Credit Suisse Group AGReiterated RatingNeutral$56.00 -> $57.00View Rating Details
4/16/2016Jefferies GroupReiterated RatingHold$51.00 -> $54.00View Rating Details
4/8/2016Nord/LBReiterated RatingBuyView Rating Details
4/8/2016Deutsche Bank AGReiterated RatingBuyView Rating Details
2/6/2016Goldman Sachs Group Inc.Reiterated RatingNeutral$60.00 -> $56.00View Rating Details
1/27/2016Bank of America Corp.Reiterated RatingNeutralView Rating Details
12/1/2015Barclays PLCUpgradeEqual Weight -> Overweight$64.00 -> $66.00View Rating Details
11/17/2015ArgusReiterated RatingBuy$70.00 -> $65.00View Rating Details
10/26/2015Societe GeneraleReiterated RatingNeutralView Rating Details
7/2/2015Piper Jaffray Cos.Reiterated RatingUnderweightView Rating Details
6/25/2015HSBCInitiated CoverageHoldView Rating Details
4/29/2015BNP ParibasInitiated CoverageNeutralView Rating Details
(Data available from 8/27/2014 forward)

Earnings

Earnings History for Merck KGaA (OTCMKTS:MKGAY)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Merck KGaA (OTCMKTS:MKGAY)
Current Year EPS Consensus Estimate: $6.49 EPS
Next Year EPS Consensus Estimate: $6.76 EPS

Dividends

Dividend History for Merck KGaA (OTCMKTS:MKGAY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Merck KGaA (OTCMKTS:MKGAY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Merck KGaA (OTCMKTS:MKGAY)
DateHeadline
finance.yahoo.com logoMerck KGaA downgraded by Berenberg (OTCMKTS:MKGAY)
finance.yahoo.com - August 12 at 6:18 PM
publicnow.com logoMerck Lifts Forecast Following Good Second Quarter (OTCMKTS:MKGAY)
www.publicnow.com - August 10 at 9:13 AM
capitalcube.com logoMerck KGaA :MKGAY-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (OTCMKTS:MKGAY)
www.capitalcube.com - August 9 at 6:27 PM
nasdaq.com logoMerck KGaA Q2 Net Income Down, But Raises 2016 Outlook (OTCMKTS:MKGAY)
www.nasdaq.com - August 4 at 9:23 AM
publicnow.com logoMerck Invests € 15 million in Liquid Crystal Window Technology (OTCMKTS:MKGAY)
www.publicnow.com - August 2 at 6:31 PM
rttnews.com logoMerck KGaA To Provide Provantage Development & Manufacturing Services To Y-mAbs (OTCMKTS:MKGAY)
www.rttnews.com - August 1 at 6:00 PM
publicnow.com logoMerck to Provide Provantage® End-to-End Development and Manufacturing Services to Y-mAbs for Lead Antibody Compound (OTCMKTS:MKGAY)
www.publicnow.com - August 1 at 8:11 AM
publicnow.com logoMerck and Nanoco Sign Agreement on Eco-Friendly Quantum Materials for Displays (OTCMKTS:MKGAY)
www.publicnow.com - August 1 at 2:08 AM
News IconMerck posts better-than-expected quarterly profit, revenue (OTCMKTS:MKGAY)
vegassports-odds.com - July 29 at 6:21 PM
publicnow.com logoMerck and AmoyDx Collaborate to Bring Liquid Biopsy RAS Biomarker Testing to China (OTCMKTS:MKGAY)
www.publicnow.com - July 28 at 2:08 AM
publicnow.com logoMerck Biopharma Innovation Cup Honors Young Scientists (OTCMKTS:MKGAY)
www.publicnow.com - July 26 at 9:08 AM
seekingalpha.com logoMerck KGaA's marketing application for Cladribine tablets accepted for review in Europe (OTCMKTS:MKGAY)
seekingalpha.com - July 18 at 11:30 AM
publicnow.com logoMerck Receives European Medicines Agency Acceptance for Review of Marketing Authorization Application for Cladribine Tablets (OTCMKTS:MKGAY)
www.publicnow.com - July 18 at 3:38 AM
publicnow.com logoDietmar Eidens Appointed Chief HR Officer (CHRO) of Merck (OTCMKTS:MKGAY)
www.publicnow.com - July 15 at 8:58 AM
publicnow.com logoMerck Advances Water Purification Systems with New High-Throughput Line (OTCMKTS:MKGAY)
www.publicnow.com - July 13 at 8:13 AM
publicnow.com logoMerck Expands Excipients Portfolio, Adding Polymers for Sustained Release Injectables (OTCMKTS:MKGAY)
www.publicnow.com - July 12 at 8:03 AM
seekingalpha.com logoLate-stage study commences assessing Merck KGaA and Pfizer's avelumab + chemo in advanced ovarian cancer (OTCMKTS:MKGAY)
seekingalpha.com - July 7 at 6:13 PM
publicnow.com logoMerck and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer (OTCMKTS:MKGAY)
www.publicnow.com - July 6 at 8:11 AM
publicnow.com logoMerck Commits €1.5 million to the Grant for Fertility Innovation (GFI) for 2016/17 (OTCMKTS:MKGAY)
www.publicnow.com - July 6 at 2:11 AM
seekingalpha.com logoOneCrinone reproductive treatment approved in Japan (OTCMKTS:MKGAY)
seekingalpha.com - July 5 at 6:00 PM
feeds.benzinga.com logoJuniper Pharmaceuticals Says Merck, Germany, Gets Japan's Regulatory Approval For OneCrinone (OTCMKTS:MKGAY)
feeds.benzinga.com - July 5 at 8:58 AM
publicnow.com logoMerck and University of Nairobi to Start Medical Oncology Fellowship Program (OTCMKTS:MKGAY)
www.publicnow.com - July 1 at 8:41 AM
finance.yahoo.com logo6:48 am Merck KGaA to present data from the pivotal Phase III TAILOR study in patients from China (OTCMKTS:MKGAY)
finance.yahoo.com - July 1 at 6:48 AM
publicnow.com logoResults of Pivotal TAILOR Study Confirm Addition of Erbitux to FOLFOX Significantly Improves Outcomes in RAS Wild-Type Metastatic Colorectal Cancer (OTCMKTS:MKGAY)
www.publicnow.com - July 1 at 4:41 AM
publicnow.com logoSuccessful Cooperation Between Merck and Agrimer in Marine-Derived Dermocosmetic Active Ingredients (OTCMKTS:MKGAY)
www.publicnow.com - July 1 at 2:11 AM
feeds.reuters.com logoBRIEF-Merck KGaA says Zeiss, Hamilton Thorne to join global fertility alliance (OTCMKTS:MKGAY)
feeds.reuters.com - June 30 at 3:48 AM
finance.yahoo.com logoMerck KGaA, Darmstadt, Germany, Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance (OTCMKTS:MKGAY)
finance.yahoo.com - June 30 at 3:15 AM
publicnow.com logoMerck Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance (OTCMKTS:MKGAY)
www.publicnow.com - June 30 at 3:11 AM
publicnow.com logoMerck Receives Frost & Sullivan Award for Meoxal® and Xirallic® NXT Lines (OTCMKTS:MKGAY)
www.publicnow.com - June 29 at 2:11 AM
publicnow.com logoMerck Expands Industry-Leading Emprove® Program to Include Filtration and Single-Use Products (OTCMKTS:MKGAY)
www.publicnow.com - June 28 at 8:11 AM
publicnow.com logoMerck to Develop Next-Generation Purification Processes with International Vaccine Institute (OTCMKTS:MKGAY)
www.publicnow.com - June 28 at 5:11 AM
seekingalpha.com logoEylea Combinations And Array's Play For Melanoma (OTCMKTS:MKGAY)
seekingalpha.com - June 25 at 9:57 AM
capitalcube.com logoETF’s with exposure to Merck KGaA : June 20, 2016 (OTCMKTS:MKGAY)
www.capitalcube.com - June 20 at 2:49 PM
publicnow.com logoMerck Family Foundation Established (OTCMKTS:MKGAY)
www.publicnow.com - June 17 at 8:19 AM
nasdaq.com logoMerck KGaA In Deal With HAPPYneuron To Offer E-Health Solution For MS Patients (OTCMKTS:MKGAY)
www.nasdaq.com - June 13 at 5:49 PM
publicnow.com logoMerck in Agreement with HAPPYneuron to Offer First-of-its Kind e-Health Solution for People Living with Multiple Sclerosis (OTCMKTS:MKGAY)
www.publicnow.com - June 13 at 3:09 AM
publicnow.com logoConsumer Health To Play A Pivotal Role In Merck’s Africa Growth Strategy (OTCMKTS:MKGAY)
www.publicnow.com - June 9 at 4:09 AM
publicnow.com logoMerck Accelerator Expands its Reach to Silicon Valley (OTCMKTS:MKGAY)
www.publicnow.com - June 9 at 3:09 AM
publicnow.com logoMerck Expands its Investment Fund Merck Ventures (OTCMKTS:MKGAY)
www.publicnow.com - June 8 at 5:08 AM
publicnow.com logoMerck Announces Survey Results Exploring Biopharma Industry’s Evolving Risk Model (OTCMKTS:MKGAY)
www.publicnow.com - June 7 at 2:08 AM
nasdaq.com logoPfizer Says Pivotal Avelumab Study Shows Positive Results In MCC (OTCMKTS:MKGAY)
www.nasdaq.com - June 6 at 9:54 AM
publicnow.com logoASCO 2016: Pivotal Avelumab Study Shows Positive Results in Metastatic Merkel Cell Carcinoma (OTCMKTS:MKGAY)
www.publicnow.com - June 6 at 9:08 AM
feeds.reuters.com logoBRIEF-Merck KGaA partners with Array BioPharma, Pierre Fabre on mCRC phase iii trial (OTCMKTS:MKGAY)
feeds.reuters.com - June 4 at 10:05 AM
publicnow.com logoMerck’s Belén Garijo Receives Prestigious Career Award (OTCMKTS:MKGAY)
www.publicnow.com - June 1 at 9:23 AM
capitalcube.com logoMerck KGaA :MKGAY-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016 (OTCMKTS:MKGAY)
www.capitalcube.com - May 26 at 12:04 PM
publicnow.com logoMerck and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting (OTCMKTS:MKGAY)
www.publicnow.com - May 18 at 5:12 PM
publicnow.com logoBringing Innovation to Patients: Merck Presents New Advances at ASCO 2016 (OTCMKTS:MKGAY)
www.publicnow.com - May 18 at 5:12 PM
publicnow.com logoMerck and Progyny Extend Collaboration for Eeva® Software to Global Level (OTCMKTS:MKGAY)
www.publicnow.com - May 9 at 9:08 AM
publicnow.com logoMerck Launches First Commercially Available Equine-Specific Multiplex Assay for Protein Biomarkers (OTCMKTS:MKGAY)
www.publicnow.com - May 9 at 8:08 AM
publicnow.com logoMerck Builds on Leading Viral and Gene Therapy Service Offering with Capacity Expansion (OTCMKTS:MKGAY)
www.publicnow.com - May 4 at 8:10 AM

Social

Merck KGaA (OTCMKTS:MKGAY) Chart for Saturday, August, 27, 2016


Last Updated on 8/27/2016 by MarketBeat.com Staff